The Cigna Group
CI
$264.41
-$5.25-1.95%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.26% | 15.33% | 20.52% | 24.23% | 26.82% |
| Total Other Revenue | 7.50% | -0.20% | -31.59% | -21.88% | -16.55% |
| Total Revenue | 11.24% | 15.26% | 20.23% | 23.96% | 26.56% |
| Cost of Revenue | 12.74% | 17.41% | 23.03% | 27.00% | 30.03% |
| Gross Profit | -1.56% | -1.80% | -0.48% | 2.49% | 3.13% |
| SG&A Expenses | -6.54% | -3.88% | -1.87% | 1.79% | 1.71% |
| Depreciation & Amortization | 2.35% | -1.50% | -2.52% | -4.54% | -6.38% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.49% | 15.88% | 21.06% | 24.87% | 27.49% |
| Operating Income | 5.25% | 1.24% | 2.02% | 4.93% | 7.28% |
| Income Before Tax | 47.68% | 131.24% | 67.72% | 71.34% | -4.43% |
| Income Tax Expenses | 0.13% | 1,337.37% | 1,093.50% | 950.36% | 957.45% |
| Earnings from Continuing Operations | 66.44% | 95.58% | 35.97% | 40.09% | -29.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 3.78% | -30.00% | -44.91% | -55.98% | -65.38% |
| Net Income | 73.47% | 102.27% | 35.33% | 39.06% | -33.50% |
| EBIT | 5.25% | 1.24% | 2.02% | 4.93% | 7.28% |
| EBITDA | 4.08% | -0.58% | -1.30% | 1.14% | 3.30% |
| EPS Basic | 81.32% | 113.27% | 43.67% | 48.07% | -29.70% |
| Normalized Basic EPS | 12.97% | 6.00% | 5.92% | 8.30% | 11.43% |
| EPS Diluted | 81.37% | 113.79% | 44.07% | 48.21% | -29.66% |
| Normalized Diluted EPS | 12.83% | 6.01% | 5.78% | 8.00% | 11.62% |
| Average Basic Shares Outstanding | -5.05% | -5.25% | -5.44% | -5.25% | -4.67% |
| Average Diluted Shares Outstanding | -4.90% | -5.24% | -5.33% | -5.01% | -4.87% |
| Dividend Per Share | 7.86% | 9.21% | 10.65% | 12.18% | 13.82% |
| Payout Ratio | -0.41% | -0.49% | -0.22% | -0.23% | 0.63% |